Rheumatoid arthritis: A disease associated with accelerated atherogenesis

Seminars in Arthritis and Rheumatism

Volumn 35, Issue 1, 2005, Pages 8-17

  Gonzalez Gay, Miguel A ^a   Gonzalez Juanatey, Carlos ^a   Martin, Javier ^b  

^a HOSPITAL XERAL CALDE   (Spain)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

Atherogenesis; Cardiovascular complications; Carotid intima media thickness; Endothelial dysfunction; Inflammatory response; Mortality; Rheumatoid arthritis

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; ANTIMALARIAL AGENT; ATORVASTATIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLICLAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLIXIMAB; METHOTREXATE;

ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BODY MASS; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DISEASE COURSE; DYSLIPIDEMIA; HUMAN; HYPERHOMOCYSTEINEMIA; INFLAMMATION; INSULIN RESISTANCE; MORTALITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SMOKING; VASCULAR ENDOTHELIUM;

ARTERIOSCLEROSIS; ARTHRITIS, RHEUMATOID; CAUSE OF DEATH; CORONARY DISEASE; HUMANS; MORTALITY; PREVALENCE;

EID: 23444439778     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2005.03.004     Document Type: Article

References (106)

1. F. Wolfe Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis J Rheumatol 24 1997 1477 1485
2. D.P. Symmons, M.A. Jones, D.L. Scott, P. Prior Long-term mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well J Rheumatol 25 1998 1072 1077
3. N.J. Goodson, N.J. Wiles, M. Lunt, E.M. Barrett, A.J. Silman, D.P. Symmons Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients Arthritis Rheum 46 2002 2010 2019
4. N. Goodson Coronary artery disease and rheumatoid arthritis Curr Opin Rheumatol 14 2002 115 120
5. F. Wolfe, B. Freundlich, W.L. Straus Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis J Rheumatol 30 2003 36 40
6. M. Boers, B. Dijkmans, S. Gabriel, H. Maradit-Kremers, J. O'Dell, T. Pincus Making an impact on mortality in rheumatoid arthritis: targeting cardiovascular comorbidity Arthritis Rheum 50 2004 1734 1739
7. I. Del Rincon, A. Escalante Atherosclerotic cardiovascular disease in rheumatoid arthritis Curr Rheumatol Rep 5 2003 278 286
8. I.D. Del Rincon, K. Williams, M.P. Stern, G.L. Freeman, A. Escalante High incidence of cardiovascular events in rheumatoid arthritis cohort not explained by traditional cardiac risk factors Arthritis Rheum 44 2001 2737 2745
9. M.A. Gonzalez-Gay, C. Garcia-Porrua, A.H. Hajeer Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis Semin Arthritis Rheum 31 2002 355 360
10. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115 126
11. D.S. Celermajer, K.E. Sorensen, V.M. Gooch, D.J. Spiegelhalter, O.I. Miller, I.D. Sullivan Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis Lancet 340 1992 1111 1115
12. A.D. Blann Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms? Blood Coagul Fibrinolysis 11 2000 623 630
13. M.C. Corretti, T.J. Anderson, E.J. Benjamin, D. Celermajer, F. Charbonneau, M.A. Creager Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 39 2002 257 265
14. N. Gokce, J.F. Keaney Jr, L.M. Hunter Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study Circulation 105 2002 1567 1572
15. K Raza, J. Thambyrajah, J.N. Townend, A.R. Exley, C. Hortas, A. Filer Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease. Circulation 102 2000 1470 1472
16. C. Gonzalez-Juanatey, A. Testa, A. Garcia-Castelo, C. Garcia-Porrua, J. Llorca, J. Vidan HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis Am J Med 114 2003 647 652
17. G. Vaudo, S. Marchesi, R. Gerli, R. Allegrucci, A. Giordano, D. Siepi Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity Ann Rheum Dis 63 2004 31 35
18. M.A. Gonzalez-Gay, C. Gonzalez-Juanatey, W.E. Ollier Endothelial dysfunction in rheumatoid arthritis: influence of HLA-DRB1 alleles Autoimmun Rev 3 2004 301 304
19. N. Sattar, D.W. McCarey, H. Capell, I.B. McInnes Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis Circulation 108 2003 2957 2963
20. H. Glosli, K.J. Tronstad, H. Wergedal, F. Muller, A. Svardal, P. Aukrust Human TNF-α in transgenic mice induces differential changes in redox status and glutathione-regulating enzymes FASEB J 16 2002 1450 1452
21. C. Hermann, B. Assmus, C. Urbich, A.M. Zeiher, S. Dimmeler Insulin-mediated stimulation of protein kinase Akt: a potent survival signaling cascade for endothelial cells Arterioscler Thromb Vasc Biol 20 2000 402 409
22. M. Yoshizumi, M.A. Perrella, J.C. Burnett Jr, M.E. Lee Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life Circ Res 73 1993 205 209
23. M. Nakamura, H. Yoshida, N. Arakawa, S. Saitoh, M. Satoh, K. Hiramori Effects of tumor necrosis factor-alpha on basal and stimulated endothelium-dependent vasomotion in human resistance vessel J Cardiovasc Pharmacol 36 2000 487 492
24. S. Dimmeler, I. Fleming, B. Fisslthaler, C. Hermann, R. Busse, A.M. Zeiher Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation Nature 399 1999 601 605
25. R.N. Maini, F.C. Breedveld, J.R. Kalden, J.S. Smolen, D. Davis, J.D. Macfarlane Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis Arthritis Rheum 41 1998 1552 1563
26. D. Hürlimann, A. Forster, G. Noll, F. Enseleit, R. Chenevard, O. Distler Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis Circulation 106 2002 2184 2187
27. C. Gonzalez-Juanatey, A. Testa, A. Garcia-Castelo, C. Garcia-Porrua, J. Llorca, M.A. Gonzalez-Gay Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody Arthritis Rheum 51 2004 447 450
28. C. Gonzalez-Juanatey, M.A. Gonzalez-Gay Rheumatoid arthritis and accelerated atherogenesis Circulation 109 2004 e328
29. C. Gonzalez-Juanatey, M.A. Gonzalez-Gay Long-term rheumatoid arthritis and endothelial dysfunction Atherosclerosis 176 2004 197 198
30. R.M. Clancy, A.R. Amin, S.B. Abramson The role of nitric oxide in inflammation and immunity Arthritis Rheum 41 1998 1141 1151
31. E.W. St Clair, W.E. Wilkinson, T. Lang, L. Sanders, M.A. Misukonis, G.S. Gilkeson Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis J Exp Med 184 1996 1173 1178
32. H. Yki-Jarkiven, R. Bergholm, M. Leirisalo-Repo Increased inflammatory activity parallels increased basal nitric oxide production and blunted response to nitric oxide in vivo in rheumatoid arthritis Ann Rheum Dis 62 2003 630 634
33. R.J. Van't Hof, L. Hocking, P.K. Wright, S.H. Ralston Nitric oxide is a mediator of apoptosis in the rheumatoid joint Rheumatology 39 2000 1004 1008
34. H. Kolb, V. Kolb-Bachofen Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? Immunol Today 19 1998 556 561
35. J.B. Weinberg Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review Mol Med 4 1998 557 591
36. M.A. Gonzalez-Gay, J. Llorca, E. Sanchez, M.A. Lopez-Nevot, M.M. Amoli, C. Garcia-Porrua Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain Rheumatology (Oxford) 43 2004 1182 1185
37. E.T. Molenaar, A.E. Voskuyl, A. Familian, G.J. van Mierlo, B.A. Dijkmans, C.E. Hack Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein Arthritis Rheum 44 2001 997 1002
38. P. Libby, P.M. Ridker Inflammation and atherosclerosis: role of C-reactive protein in risk assessment Am J Med 116 suppl 6A 2004 9 16
39. S. Verma, C.H. Wang, S.H. Li, A.S. Dumont, P.W. Fedak, M.V. Badiwala A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis Circulation 106 2002 913 919
40. S.K. Venugopal, S. Devaraj, I. Yuhanna, P. Shaul, I. Jialal Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells Circulation 106 2002 1439 1441
41. I. Del Rincon, K. Williams, M.P. Stern, G.L. Freeman, D.H. O'Leary, A. Escalante Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects Arthritis Rheum 48 2003 1833 1840
42. Gonzalez-Gay MA, Gonzalez-Juanatey C, Piñeiro A, Garcia-Porrua C, Testa A, Llorca J. High-grade C reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 2005 (in press).
43. R. Hallgren, C. Berne Glucose intolerance in patients with chronic inflammatory diseases is normalized by glucocorticoids Acta Med Scand 213 1983 351 355
44. K.L. Svenson, T. Pollare, H. Lithell, R. Hallgren Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance Metabolism 37 1988 125 130
45. G. Paolisso, G. Valentini, D. Giugliano, G. Marrazzo, R. Tirri, M. Gallo Evidence for peripheral impaired glucose handling in patients with connective tissue diseases Metabolism 40 1991 902 907
46. P.H. Dessein, B.I. Joffe, A. Stanwix, A.S. Botha, Z. Moomal The acute phase response does not fully predict the presence of insulin resistance and dyslipidemia in inflammatory arthritis J Rheumatol 29 2002 462 466
47. R. Rosmond, M.F. Dallman, P. Bjorntorp Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities J Clin Endocrinol Metab 83 1998 1853 1862
48. A. Hautanen, K. Raikkonen, H. Adlercreutz Associations between pituitary-adrenocortical function and abdominal obesity, hyperinsulinaemia and dyslipidaemia in normotensive males J Intern Med 241 1997 451 461
49. H.O. Steinberg, H. Chaker, R. Leaming, A. Johnson, G. Brechtel, A.D. Baron Obesity/insulin resistance is associated with endothelial dysfunction Implications for the syndrome of insulin resistance. J Clin Invest 97 1996 2601 2610
50. M. Fukuzawa, J. Satoh, X. Qiang, S. Miyaguchi, Y. Sakata, T. Nakazawa Inhibition of tumor necrosis factor-alpha with anti-diabetic agents Diabetes Res Clin Pract 43 1999 147 154
51. G.S. Hotamisligil, P. Peraldi, A. Budavari, R. Ellis, M.F. White, B.M. Spiegelman IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance Science 27 1996 665 668
52. V. Manninen, M.O. Elo, M.H. Frick, K. Haapa, O.P. Heinonen, P. Heinsalmi Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study JAMA 260 1988 641 651
53. N. Sattar, J.R. Petrie, A.J. Jaap The atherogenic lipoprotein phenotype and vascular endothelial dysfunction Atherosclerosis 138 1998 229 235
54. G.H. Dahlen Lp(a) lipoprotein in cardiovascular disease Atherosclerosis 108 1994 111 126
55. Y.B. Park, S.K. Lee, W.K. Lee, C.H. Suh, C.W. Lee, C.H. Lee Lipid profiles in untreated patients with rheumatoid arthritis J Rheumatol 26 1999 1701 1704
56. YH Lee, S.J. Choi, J.D. Ji, H.S. Seo, G.G. Song Lipoprotein(a) and lipids in relation to inflammation in rheumatoid arthritis Clin Rheumatol 19 2000 324 325
57. R. Munro, E. Morrison, A.G. McDonald, J.A. Hunter, R. Madhok, H.A. Capell Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis Ann Rheum Dis 56 1997 374 377
58. W. Khovidhunkit, R.A. Memon, K.R. Feingold, C. Grunfeld Infection and inflammation-induced proatherogenic changes of lipoproteins J Infect Dis 181 suppl 3 2000 S462 S472
59. C.J. Haagsma, H.J. Blom, P.L. van Riel, M.A. van't Hof, B.A. Giesendorf, D. van Oppenraaij-Emmerzaal Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis Ann Rheum Dis 58 1999 79 84
60. P.F. Jacques, A.G. Bostom, P.W. Wilson, S. Rich, I.H. Rosenberg, J. Selhub Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort Am J Clin Nutr 73 2001 613 621
61. R. Clarke, L. Daly, K. Robinson, E. Naughten, S. Cahalane, B. Fowler Hyperhomocysteinemia: an independent risk factor for vascular disease N Engl J Med 324 1991 1149 1155
62. A. Hernanz, A. Plaza, E. Martin-Mola, E. De Miguel Increased plasma levels of homocysteine and other thiol compounds in rheumatoid arthritis women Clin Biochem 32 1999 65 70
63. H.K. Choi, M.A. Hernan, J.D. Seeger, J.M. Robins, F. Wolfe Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study Lancet 359 2002 1173 1177
64. S.L. Morgan, J.E. Baggott, J.Y. Lee, G.S. Alarcon Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention J Rheumatol 25 1998 441 446
65. P.E. Lazzerini, P.L. Capecchi, S. Bisogno, M. Galeazzi, R. Marcolongo, F.L. Pasini Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. Ann Rheum Dis 62 2003 694 695
66. 6 status is associated with severity of symptoms in patients with rheumatoid arthritis Am J Med 114 2003 283 287
67. C. Maziere, M. Auclair, J.C. Maziere Tumor necrosis factor enhances low density lipoprotein oxidative modification by monocytes and endothelial cells FEBS Lett 338 1994 43 46
68. J.K. Gambhir, P. Lali, A.K. Jain Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis Clin Biochem 30 1997 351 355
69. V. Honkanen, Y.T. Konttinen, H. Mussalo-Rauhamaa Vitamins A and E, retinol binding protein and zinc in rheumatoid arthritis Clin Exp Rheumatol 7 1989 465 469
70. A. McEntegart, H.A. Capell, D. Creran, A. Rumley, M. Woodward, G.D. Lowe Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis Rheumatology (Oxford) 40 2001 640 644
71. G. Grignani, A. Maiolo Cytokines and hemostasis Haematologica 85 2000 967 972
72. C.U. Chae, R.T. Lee, N. Rifai, P.M. Ridker Blood pressure and inflammation in apparently healthy men Hypertension 38 2001 399 403
73. A.J. Silman, J. Newman, A.J. MacGregor Cigarette smoking increases the risk of rheumatoid arthritis Results from a nationwide study of disease-discordant twins. Arthritis Rheum 39 1996 732 735
74. D. Hutchinson, L. Shepstone, R. Moots, J.T. Lear, M.P. Lynch Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA Ann Rheum Dis 60 2001 223 227
75. F. Wolfe The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis J Rheumatol 27 2000 630 637
76. S. Wallberg-Jonsson, H. Johansson, M.L. Ohman, S. Rantapaa-Dahlqvist Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis A retrospective cohort study from disease onset. J Rheumatol 26 1999 2562 2571
77. N.J. Goodson, A.J. Silman, D.J. Pattison, M. Lunt, D. Bunn, R. Luben Traditional cardiovascular risk factors measured prior to the onset of inflammatory polyarthritis Rheumatology (Oxford) 43 2004 731 736
78. J. Walsmith, R. Roubenoff Cachexia in rheumatoid arthritis Int J Cardiol 85 2002 89-9
79. H.M. Kremers, P.J. Nicola, C.S. Crowson, K.V. Ballman, S.E. Gabriel Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis Arthritis Rheum 50 2004 3450 3457
80. M.L. Bots, A. Hofman, P.T. De Jong, D.E. Grobbee Common carotid intima-media thickness as an indicator of atherosclerosis at other sites of the carotid artery The Rotterdam Study. Ann Epidemiol 6 1996 147 153
81. G. Heiss, A.R. Sharrett, R. Barnes, L.E. Chambless, M. Szklo, C. Alzola Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study Am J Epidemiol 134 1991 250 256
82. P. Pignoli, E. Tremoli, A. Poli, P. Oreste, R. Paoletti Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging Circulation 74 1986 1399 1406
83. J.T. Salonen, R. Salonen Ultrasonographically assessed carotid morphology and the risk of coronary heart disease Arterioscler Thromb 11 1991 1245 1249
84. R. Li, J. Cai, C. Tegeler, P. Sorlie, P.A. Metcalf, G. Heiss Reproducibility of extracranial carotid atherosclerotic lesions assessed by B-mode ultrasound: the Atherosclerosis Risk in Communities Study Ultrasound Med Biol 22 1996 791 799
85. J.P. Lekakis, C.M. Papamichael, A.T. Cimponeriu, K.S. Stamatelopoulos, T.G. Papaioannou Atherosclerotic changes of extracoronary arteries are associated with the extent of coronary atherosclerosis Am J Cardiol 85 2000 949 952
86. P.C. Simons, A. Algra, M.L. Bots, D.E. Grobbee, Y. van der Graaf Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients The SMART Study (Second Manifestations of Arterial disease). Circulation 100 1999 951 957
87. Y. Kumeda, M. Inaba, H. Goto Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis Arthritis Rheum 46 2002 1489 1497
88. Y.B. Park, C.W. Ahn, H.K. Choi Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound Arthritis Rheum 46 2002 1714 1719
89. J.K. Alkaabi, M. Ho, R. Levison, T. Pullar, J.J. Belch Rheumatoid arthritis and macrovascular disease Rheumatology (Oxford) 42 2003 292 297
90. C. Gonzalez-Juanatey, J. Llorca, A. Testa, J. Revuelta, C. Garcia-Porrua, M.A. Gonzalez-Gay Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease Medicine (Baltimore) 82 2003 407 413
91. Abu-Shakra M, Polyshchuk I, Szendro G, Bolotin A, Jonathan B-S, Fluser D, et al. Duplex study of the carotid and femoral arteries of patients with RA: a controlled study. Semin Arthritis Rheum (in press).
92. M. Nagata-Sakurai, M. Inaba, H. Goto, Y. Kumeda, Y. Furumitsu, K. Inui Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis Arthritis Rheum 48 2003 3061 3067
93. E. Krishnan, V.B. Lingala, G. Singh Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis Circulation 110 2004 1774 1779
94. D. Krause, B. Schleusser, G. Herborn, R. Rau Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis Arthritis Rheum 43 2000 14 21
95. D.J. Wallace, M. Linker-Israeli, A.L. Metzger, V.J. Stecher The relevance of antimalarial therapy with regard to thrombosis, hypercholesterolemia and cytokines in SLE Lupus 2 suppl 1 1993 S13 S15
96. W. Palinski, C. Napoli Unraveling pleiotropic effects of statins on plaque rupture Arterioscler Thromb Vasc Biol 22 2002 1745 1750
97. P.L. Meroni, C. Luzzana, D. Ventura Anti-inflammatory and immunomodulating properties of statins An additional tool for the therapeutic approach of systemic autoimmune diseases? Clin Rev Allergy Immunol 23 2002 263 277
98. I.B. McInnes, D.W. McCarey, N. Sattar Do statins offer therapeutic potential in inflammatory arthritis? Ann Rheum Dis 63 2004 1535 1537
99. B.P. Leung, N. Sattar, A. Crilly, M. Prach, D.W. McCarey, H. Payne A novel anti-inflammatory role for simvastatin in inflammatory arthritis J Immunol 170 2003 1524 1530
100. D.W. McCarey, I.B. McInnes, R. Madhok, R. Hampson, O. Scherbakov, I. Ford Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial Lancet 363 2004 2015 2021
101. W.H. Leung, C.P. Lau, C.K. Wong Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients Lancet 341 1993 1496 1500
102. T.J. Anderson, I.T. Meredith, A.C. Yeung, B. Frei, A.P. Selwyn, P. Ganz The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion N Engl J Med 332 1995 488 493
103. F. Perticone, R. Ceravolo, R. Maio, C. Cloro, M. Candigliota, A. Scozzafava Effects of atorvastatin and vitamin C on endothelial function of hypercholesterolemic patients Atherosclerosis 152 2000 511 518
104. A. Masumoto, Y. Hirooka, K. Hironaga, K. Eshima, S. Setoguchi, K. Egashira Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin) Am J Cardiol 88 2001 1291 1294
105. J.A. Beckman, J.K. Liao, S. Hurley, L.A. Garrett, D. Chui, D. Mitra Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein Circ Res 95 2004 217 223
106. M. Fukuzawa, J. Satoh, X. Qiang, S. Miyaguchi, Y. Sakata, T. Nakazawa Inhibition of tumor necrosis factor-alpha with anti-diabetic agents Diabetes Res Clin Pract 43 1999 147 154